Casual effect of methotrexate+etanercept/infliximab on survival of patients with rheumatoid arthritis

Background and objectives: Following the discovery of new drugs, physicians and pharmaceutical companies have become interested in examining patients’ mortality and morbidity rates. In this respect, the effects of methotrexate (MTX)+etanercept/infliximab (ETA/INF) therapy on the survival of rheumato...

Descripción completa

Detalles Bibliográficos
Autores principales: Akhlaghi, Saeed, Sahebari, Maryam, Mahmoodi, Mahmoud, Yaseri, Mehdi, Mansournia, Mohammad Ali, Zeraati, Hojjat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503221/
https://www.ncbi.nlm.nih.gov/pubmed/31118865
http://dx.doi.org/10.2147/POR.S194408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503221/
https://www.ncbi.nlm.nih.gov/pubmed/31118865
http://dx.doi.org/10.2147/POR.S194408

Ejemplares similares